-
1 Comment
InspireMD, Inc is currently in a long term downtrend where the price is trading 39.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.0.
InspireMD, Inc's total revenue sank by 84.4% to $158K since the same quarter in the previous year.
Its net income has dropped by 50.7% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 39.5% to $-2M since the same quarter in the previous year.
Based on the above factors, InspireMD, Inc gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | US45779A8466 |
| Beta | 0.94 |
|---|---|
| PE Ratio | None |
| Target Price | 5 |
| Market Cap | 63M |
| Dividend Yield | None |
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NSPR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026